Globus Medical, Inc. (GMED)
80.68
+0.20
(+0.25%)
USD |
NYSE |
Sep 02, 16:00
80.68
0.00 (0.00%)
After-Hours: 20:00
Globus Medical Research and Development Expense (TTM) : 147.06M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 147.06M |
| March 31, 2026 | 150.48M |
| December 31, 2025 | 146.94M |
| September 30, 2025 | 131.57M |
| June 30, 2025 | 128.88M |
| March 31, 2025 | 126.84M |
| December 31, 2024 | 138.54M |
| September 30, 2024 | 170.00M |
| June 30, 2024 | 163.95M |
| March 31, 2024 | 147.60M |
| December 31, 2023 | 124.01M |
| September 30, 2023 | 91.12M |
| June 30, 2023 | 80.49M |
| March 31, 2023 | 76.54M |
| December 31, 2022 | 72.86M |
| September 30, 2022 | 70.22M |
| June 30, 2022 | 67.37M |
| March 31, 2022 | 65.52M |
| December 31, 2021 | 63.03M |
| September 30, 2021 | 61.56M |
| June 30, 2021 | 60.13M |
| March 31, 2021 | 59.64M |
| December 31, 2020 | 60.12M |
| September 30, 2020 | 60.37M |
| June 30, 2020 | 60.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 61.15M |
| December 31, 2019 | 60.07M |
| September 30, 2019 | 58.34M |
| June 30, 2019 | 59.36M |
| March 31, 2019 | 57.13M |
| December 31, 2018 | 55.50M |
| September 30, 2018 | 53.15M |
| June 30, 2018 | 48.51M |
| March 31, 2018 | 45.70M |
| December 31, 2017 | 43.68M |
| September 30, 2017 | 45.91M |
| June 30, 2017 | 45.29M |
| March 31, 2017 | 45.82M |
| December 31, 2016 | 45.36M |
| September 30, 2016 | 41.55M |
| June 30, 2016 | 40.70M |
| March 31, 2016 | 38.52M |
| December 31, 2015 | 36.98M |
| September 30, 2015 | 35.55M |
| June 30, 2015 | 34.29M |
| March 31, 2015 | 32.90M |
| December 31, 2014 | 31.69M |
| September 30, 2014 | 29.70M |
| June 30, 2014 | 28.12M |
| March 31, 2014 | 27.47M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Teleflex, Inc. | 195.47M |
| The Cooper Cos., Inc. | 172.80M |
| Intuitive Surgical, Inc. | 1.414B |
| Stryker Corp. | 1.606B |
| Zimmer Biomet Holdings, Inc. | 442.90M |